Neflamapimod: Ph IIa Study 302 data

The double-blind, Dutch Phase II Study 302 in 15 evaluable patients ages 60-85 with mild cognitive impairment (MCI) due to

Read the full 205 word article

How to gain access

Continue reading with a
two-week free trial.